ARCHIVES

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

This article is from The Cancer Letter archive.

Vol. 40 No. 22 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Van Andel Institute to Build Epigenetics Hub

February 28, 2014

Some NCAB Members Lack Understanding f Bypass Budget’s Value, Purpose

September 1, 1989

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003

UNM Cancer Center Appoints Four Leaders

May 24, 2013

New CCP Lineup remains Unclear; 11 Bases OK’d

April 5, 1991

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

September 3, 1993